Radiate equity: the inclusion of radiation oncology and other specialties in lymphoma collaborative groups.

The Lancet Haematology Pub Date : 2025-05-16 DOI:10.1016/s2352-3026(25)00080-8

Omran Saifi,Chelsea C Pinnix,Chris R Kelsey,Leslie K Ballas,Sarah A Milgrom,Ranjana Advani,Margaret T Kasner,Stella Flampouri,Stephanie A Terezakis,Mark Sellmyer,John P Plastaras,Bradford S Hoppe

{"title":"Radiate equity: the inclusion of radiation oncology and other specialties in lymphoma collaborative groups.","authors":"Omran Saifi,Chelsea C Pinnix,Chris R Kelsey,Leslie K Ballas,Sarah A Milgrom,Ranjana Advani,Margaret T Kasner,Stella Flampouri,Stephanie A Terezakis,Mark Sellmyer,John P Plastaras,Bradford S Hoppe","doi":"10.1016/s2352-3026(25)00080-8","DOIUrl":null,"url":null,"abstract":"There has been a notable decrease in the use of radiation in lymphoma clinical practice and research in recent years. The NRG Hematologic Malignancies Working Group aimed to assess the inclusion of radiation oncology alongside haematology and oncology, pathology and molecular biology, and diagnostic radiology and nuclear medicine in lymphoma academic leadership positions. The haematology and oncology specialty had the highest representation among National Comprehensive Cancer Network lymphoma guideline committees, lymphoma research cooperative groups, lymphoma research foundations, and the editorial boards of seven high-impact haematology journals, with under-representation of radiation oncology and other specialties, such as diagnostic radiology and nuclear medicine. The NRG Hematologic Malignancies Working Group advocates for increased multidisciplinary representation and collaboration to enhance the quality of care and improve outcomes for patients with lymphoma.","PeriodicalId":501011,"journal":{"name":"The Lancet Haematology","volume":"40 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet Haematology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s2352-3026(25)00080-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

There has been a notable decrease in the use of radiation in lymphoma clinical practice and research in recent years. The NRG Hematologic Malignancies Working Group aimed to assess the inclusion of radiation oncology alongside haematology and oncology, pathology and molecular biology, and diagnostic radiology and nuclear medicine in lymphoma academic leadership positions. The haematology and oncology specialty had the highest representation among National Comprehensive Cancer Network lymphoma guideline committees, lymphoma research cooperative groups, lymphoma research foundations, and the editorial boards of seven high-impact haematology journals, with under-representation of radiation oncology and other specialties, such as diagnostic radiology and nuclear medicine. The NRG Hematologic Malignancies Working Group advocates for increased multidisciplinary representation and collaboration to enhance the quality of care and improve outcomes for patients with lymphoma.

查看原文本刊更多论文

放射公平：在淋巴瘤合作小组中纳入放射肿瘤学和其他专业。

近年来，放疗在淋巴瘤临床实践和研究中的应用明显减少。NRG血液恶性肿瘤工作组旨在评估放射肿瘤学、血液学和肿瘤学、病理学和分子生物学、诊断放射学和核医学在淋巴瘤学术领导地位中的纳入情况。血液学和肿瘤学专业在国家综合癌症网络淋巴瘤指南委员会、淋巴瘤研究合作小组、淋巴瘤研究基金会和七个高影响力血液学期刊的编辑委员会中具有最高的代表性，而放射肿瘤学和其他专业（如诊断放射学和核医学）的代表性较低。NRG血液恶性肿瘤工作组提倡增加多学科代表和合作，以提高护理质量，改善淋巴瘤患者的预后。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

The Lancet Haematology

自引率

0.00%

发文量